Biogen Wants Jury Verdict Overruled In MS Drug Patent Row
Biogen MA Inc. on Friday asked a New Jersey federal judge to override a jury's verdict finding claims in a patent covering the multiple sclerosis treatment Avonex invalid or to redo...To view the full article, register now.
Already a subscriber? Click here to view full article